DUPILUMAB

478975 reported adverse events

Drug classes: Interleukin-4 Receptor alpha Antagonist [EPC]

These side effects are most commonly reported by patients taking DUPILUMAB:

# Side effect Count
0 PRURITUS 58692
1 DERMATITIS ATOPIC 45026
2 PRODUCT USE IN UNAPPROVED INDICATION 41225
3 RASH 38629
4 INJECTION SITE PAIN 36707
5 DRUG INEFFECTIVE 30015
6 ECZEMA 26626
7 DRY SKIN 25981
8 PRODUCT DOSE OMISSION ISSUE 25295
9 CONDITION AGGRAVATED 20686
See all common reactions for DUPILUMAB

DUPILUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 REBOUND ATOPIC DERMATITIS 2005 0.9965
1 REBOUND ECZEMA 2010 0.9858
2 DERMATITIS ATOPIC 45026 0.9133
3 EOSINOPHILIC OESOPHAGITIS 1830 0.7165
4 NEURODERMATITIS 2356 0.6851
5 ECZEMA INFANTILE 58 0.6667
6 PERIORBITAL IRRITATION 201 0.6361
7 EXPOSURE VIA SKIN CONTACT 13934 0.6244
8 SKIN WEEPING 1946 0.5928
9 ECZEMA EYELIDS 297 0.5646
See all enriched reactions for DUPILUMAB